*ncbi.life
			MedGen

  Source:		MedGen UID: 22655


     		Viral vaccine

			Definition
			Any vaccine preparation composed of a live,
			attenuated, inactivated, killed or recombinant
			virus. Administration of a viral vaccine is to
			provide prophylaxis against viral disease or
			used as a vehicle to treat cancers.

			Related Concepts
			Adenovirus Vaccine
			Recombinant Fowlpox-gp100p209
			rF-PSA/PSMA/TRICOM
			Rotavirus vaccine
			Yellow fever vaccine
			antiviral
			SARS-CoV-2
			oral
			antibody
			immunization
			influenza
			deletion

			BioProject
			PRJNA264130 Responses to Varicella Zoster
			Virus Vaccination

			PRJNA264131 Responses to Varicella Zoster
			Virus Vaccination

			PRJNA146547 Synthetic double stranded RNA
			reliably induces innate immunity similar to a live
			viral vaccine in humans

			PubMed
			32235848 Modification of Adenovirus vaccine
			vector-induced immune responses by expression
			of a signalling molecule.

			32214704 Bioinformatical study on the
			proteomics and evolution of SARS-CoV.

			32209114 Porous gold nanoparticles for
			attenuating infectivity of influenza A virus.

			32194995 The outbreak of SARS-CoV-2
			pneumonia calls for viral vaccines.

			31217437 Adenoviral vaccine targeting multiple
			neoantigens as strategy to eradicate large
			tumors combined with checkpoint blockade.

			31211446 Differences in smolt status affect the
			resistance of Atlantic salmon (Salmo salar L.)
			against infectious pancreatic necrosis, while
			vaccine-mediated protection is unaffected.

			31163292 How the gut microbiome regulates
			host immune responses to viral vaccines.

			31127400 Large-scale microcarrier culture of
			HEK293T cells and Vero cells in single-use
			bioreactors.

			31121217 Exploitation of glycosylation in
			enveloped virus pathobiology.

			31113974 Thermal Stabilization of Viral
			Vaccines in Low-Cost Sugar Films.

			31110074 A Phase 1 Dose Escalation Trial of
			BN-CV301, a Recombinant Poxviral Vaccine
			Targeting MUC1 and CEA with Costimulatory
			Molecules.

			31104946 Influenza Antigen Engineering
			Focuses Immune Responses to a Subdominant
			but Broadly Protective Viral Epitope.

			31096061 Nanoencapsulation of
			inactivated-viral vaccine using chitosan
			nanoparticles: Evaluation of its protective
			efficacy and immune modulatory effects in olive
			flounder (Paralichthys olivaceus) against viral
			haemorrhagic septicaemia virus (VHSV)
			infection.

			31092579 The Effect of Age on the
			Immunogenicity of the Live Attenuated Zoster
			Vaccine Is Predicted by Baseline Regulatory T
			Cells and VZV-Specific T Cell Immunity.

			31047676 Semi-perfusion cultures of
			suspension MDCK cells enable high cell
			concentrations and efficient influenza A virus
			production.

			31040832 Structural Vaccinology for Viral
			Vaccine Design.

			31022927 Characterization of EIAV env
			Quasispecies during Long-Term Passage In
			Vitro: Gradual Loss of Pathogenicity.

			30996103 Oral vaccination with
			replication-competent adenovirus in mice
			reveals the dissemination of the viral vaccine
			beyond the gastrointestinal tract.

			30996093 A genome-wide haploid genetic
			screen identifies heparan sulfate-associated
			genes and the macropinocytosis modulator
			TMED10 as factors supporting vaccinia virus
			infection.

			30992598 Vaccine usage in western Canadian
			cow-calf herds.

			30984178 Unveiling Integrated Functional
			Pathways Leading to Enhanced Respiratory
			Disease Associated With Inactivated
			Respiratory Syncytial Viral Vaccine.

			30946751 Correlation between herpes simplex
			virus neutralizing antibody titers determined by
			ELVIS cell and traditional plaque reduction
			assays.

			30945978 The vaccines-associated Arthus
			reaction.

			30906919 From prevention to cure,
			repurposing anti-viral vaccines for cancer
			immunotherapy.

			Clinical Trials
			3204617 Safety and Immunogenicity Study of
			DNA.HTI, MVA.HTI and ChAdOx1.HTI in
			HIV-1-positive Patients(AELIX-002)

			3202719 Duration of IPV Priming and Antibody
			Decay

			3148990 Study to Evaluate the
			Immunogenicity, Reatogenicity and Safety of
			Double Viral Vaccine (MR) for Measles and
			Rubella

			2425410 Analysis of Viral Infections' Exposition
			Preceding the Type 1 Diabetes (T1D)
			Diagnostic in Children of the Isis-Diab Cohort.
			Search for Explanations of of the Disease's
			Early Onset

			2415166 Influenza Challenge in Mood
			Disorders

			2291263 Immunogenicity of Intramuscular
			Inactivated Poliovirus Vaccine

			2196285 Study to Evaluate Safety and
			Imunogenicity of Double Viral Vaccine (MR) for
			Measles and Rubella

			2179515 Safety and Tolerability of a Modified
			Vaccinia Ankara (MVA)-Based Vaccine Modified
			to Express Brachyury and T-cell Costimulatory
			Molecules (MVA-Brachyury-TRICOM)

			2015104 Study of Bacillus Calmette-Guerin
			(BCG) Combined With PANVAC Versus BCG
			Alone in Adults With High Grade Non-Muscle
			Invasive Bladder Cancer Who Failed At Least 1
			Course of BCG

			1991899 Study of Immunogenicity,
			Reactogenicity and Safety of the Combined
			Measles, Mumps and Rubella Vaccine
			Produced by Bio-Manguinhos/Fiocruz in
			Children 12-15 Months of Age, Followed by
			Tetraviral Vaccine in Children 15-18 Months.

			1813604 Immunogenicity of Inactivated and
			Live Polio Vaccines

			1635816 Immunogenicity of SA 14-14-2 JE
			Vaccine

			1581164 Studies of the Immune Response to
			Vaccination After Hematopoietic Stem Cell
			Transplantation

			1313715 A Clinical Trial for Inactivated Vaccine
			(Vero Cell) Against EV71 in Chinese Children
			and Infants

			1267903 A Clinical Trial for Inactivated
			Vaccine(Vero Cell) Against EV71 in Chinese
			Healthy Young Adults and Children

			922259 Safety and Immunogenicity of Live
			Influenza A Vaccine for Avian Influenza H7N7

			817661 Vitamin A and Maternal-infant Flu
			Vaccine Response

			764998 Influenza Vaccine in HIV

			623753 Evaluate Tolerability of a
			Multi-envelope, Prime-boost HIV Vaccine in
			Healthy Adults

			586469 A Randomized Study to Compare the
			Safety and Immunogenicity of FluviralĀ® Made
			With New Versus Aged Bulk

     		                         Embed       Tweet       Print